Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Posner

Showing results (131-140 of 247) with videos related to

Pageof 25
Sort By:
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 6, 2013
Reduced impact of nodal metastases as a prognostic factor for tonsil cancer in the HPV eraPeter M Vila, Chaz L Stucken, Luc G T Morris, et al.
The Journal of Clinical Investigation|August 1, 1993
V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials NetworkD C Montefiori, B S Graham, J Zhou, et al.
Plos One|June 16, 2016
Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus VulgarisAgnes S Lo, Xuming Mao, Eric M Mukherjee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2011
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trialM R Posner, J H Lorch, O Goloubeva, et al.
Virology|August 1, 1994
Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitroP P Jagodzinski, R Wiaderkiewicz, G Kurzawski, et al.
Oral Oncology|March 9, 2019
Real-time PCR HPV genotyping in fine needle aspirations of metastatic head and neck squamous cell carcinoma: Exposing the limitations of conventional p16 immunostainingF El-Salem, M Mansour, M Gitman, et al.
Clinical Immunology (Orlando, Fla.)|April 26, 2006
Pathogenic human monoclonal antibody against desmoglein 3Shih-Wei Yeh, Lisa A Cavacini, Kailash C Bhol, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 1, 2001
An artificial lung reduces pulmonary impedance and improves right ventricular efficiency in pulmonary hypertensionJ W Haft, P Montoya, O Alnajjar, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 18, 2000
Development of specific monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor markers SCCA1 and SCCA2S Cataltepe, C Schick, C J Luke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2022
Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal CarcinomaBarry M Berger, Glenn J Hanna, Marshall R Posner, et al.
Pageof 25

Showing results (131-140 of 247) with videos related to

Sort By:
Pageof 25
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 6, 2013
Reduced impact of nodal metastases as a prognostic factor for tonsil cancer in the HPV eraPeter M Vila, Chaz L Stucken, Luc G T Morris, et al.
The Journal of Clinical Investigation|August 1, 1993
V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials NetworkD C Montefiori, B S Graham, J Zhou, et al.
Plos One|June 16, 2016
Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus VulgarisAgnes S Lo, Xuming Mao, Eric M Mukherjee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2011
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trialM R Posner, J H Lorch, O Goloubeva, et al.
Virology|August 1, 1994
Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitroP P Jagodzinski, R Wiaderkiewicz, G Kurzawski, et al.
Oral Oncology|March 9, 2019
Real-time PCR HPV genotyping in fine needle aspirations of metastatic head and neck squamous cell carcinoma: Exposing the limitations of conventional p16 immunostainingF El-Salem, M Mansour, M Gitman, et al.
Clinical Immunology (Orlando, Fla.)|April 26, 2006
Pathogenic human monoclonal antibody against desmoglein 3Shih-Wei Yeh, Lisa A Cavacini, Kailash C Bhol, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 1, 2001
An artificial lung reduces pulmonary impedance and improves right ventricular efficiency in pulmonary hypertensionJ W Haft, P Montoya, O Alnajjar, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 18, 2000
Development of specific monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor markers SCCA1 and SCCA2S Cataltepe, C Schick, C J Luke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2022
Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal CarcinomaBarry M Berger, Glenn J Hanna, Marshall R Posner, et al.
Pageof 25